Please login to the form below

Not currently logged in
Email:
Password:

Teva appoints Timothy Wright as business development head

The former Covidien Pharma president mostrecently led a US cancer centre

Teva has appointed Timothy Wright as its new head of business development, strategy and innovation.

He joins the Israeli pharma company from The Ohio State University Comprehensive Cancer Center, where he served as director of its Drug Discovery and Development Institute.

Prior to that Wright spent more than 25 years in pharma and biotech, most recently as president of Covidien Pharma from 2007-10.

Before that he was CEO (Interim) and Presidentat AAI Pharmaceuticals/Xanodyne and held various roles at Elan Pharmaceuticals and DuPont Merck Pharmaceutical Company.

In his new, newly-created role Wright, whose appointment will be effective from April 13, will be responsible for identifying new sources of innovation and growth that are extensions of Teva's current business model.

Erez Vigodman, Teva's president and CEO, said: “The addition of Tim to our leadership team complements the strong management capabilities we have in Teva. He has a wealth of global experience which will serve us well as we look to create a new and exciting future for Teva.

“Tim is known for leading the transformation of large companies. His significant experience across various aspects of healthcare and unique perspective will enable us to realise our full potential at this critical time of change in the pharmaceutical industry.”

26th March 2015

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

How do companies prepare for reimbursement?
Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
EHR clinical trials
Integrating electronic health records into clinical trials
How organisations are working to realise the research potential of EHRs...
Mike Elliott Gilead
Keeping up the fight against HIV and using the lessons to tackle other threats
Danny Buckland interviews Gilead’s Mike Elliott...

Infographics